![\"\"](\"http:\/\/www.compumedics.com.au\/wp-content\/uploads\/2023\/07\/Somfit-pro-patient2-1024x562.jpg\")
<\/p>\n<\/p>\n
<\/p>\n
Compumedics is pleased to announce key strategic milestone execution activities regarding its novel Somfit\u00ae technology platform.<\/p>\n
Following the signing of a Memorandum of Understanding in August last year, Compumedics is pleased to announce that it has now signed an initial 5-year supply agreement with the leading provider of Home Sleep Testing (HST) services in Australia. The Supply Agreement is to supply the Somfit Pro, which includes recurring software as a service (SaaS) fees and consumable supplies for their home sleep testing business. The initial first year commitment is approximately $1.0m, which includes approximately $0.5m of recurring SaaS revenues. It is anticipated that SaaS revenues will grow to approximately $1.0m annually over the agreement period. The Supply Agreement is for 100% of their HST services business and represents close to 20% of the HST testing market in Australia.<\/p>\n
This supply agreement is a national agreement for their market segment, and we continue to progress a number of other Somfit agreements across Australia as part of the go-to market strategy for point of care testing highlighted in the September 2022 announcement to the ASX. The go-to market strategy has been developed around an initial focus in Australia and is currently being executed, targeting three main areas:<\/p>\n
\u2022 The existing Obstructive Sleep Apnea (OSA) Home Sleep Testing (HST) market<\/strong> This Supply Agreement with this leading HST service provider addresses the existing OSA HST market in Australia.<\/p>\n Compumedics anticipates further announcements as it concludes state-based distribution arrangements across Australia and then as it enters the much larger US market.<\/p>\n For more information on Somfit :\u00a0 Visit the Somfit product page<\/a> or contact your local Compumedics representative<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Compumedics is pleased to announce key strategic milestone execution activities regarding its novel Somfit\u00ae technology platform. Following the signing of a Memorandum of Understanding in August last year, Compumedics is pleased to announce that it has now signed an […]<\/p>\n","protected":false},"author":3,"featured_media":13110,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[97],"tags":[],"class_list":["post-13106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/posts\/13106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/comments?post=13106"}],"version-history":[{"count":0,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/posts\/13106\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/media\/13110"}],"wp:attachment":[{"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/media?parent=13106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/categories?post=13106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/de\/wp-json\/wp\/v2\/tags?post=13106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u2022 The primary care market for sleep screening and OSA diagnosis and<\/strong>
\n\u2022 Supporting the diagnosis of Insomnia and circadian rhythm disorders.<\/strong><\/p>\n